JMT-206

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameJMT-206
Drug Alias NameJMT206JMT-206
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionActivin receptor type-2A inhibitorsActivin receptor type-2B inhibitors
TargetsActivin receptor type-2AActivin receptor type-2B
Therapy Area/IndicationsOverweightBody WeightObesity +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Jmt-Bio Inc
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesCSPC Pharmaceutical Group LtdShanghai Jmt-Bio Inc
Inactive CompaniesN/A
Active IndicationsOverweightBody WeightObesity +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A